DZ1926A1 - Formulations pharmaceutiques. - Google Patents
Formulations pharmaceutiques.Info
- Publication number
- DZ1926A1 DZ1926A1 DZ950107A DZ950107A DZ1926A1 DZ 1926 A1 DZ1926 A1 DZ 1926A1 DZ 950107 A DZ950107 A DZ 950107A DZ 950107 A DZ950107 A DZ 950107A DZ 1926 A1 DZ1926 A1 DZ 1926A1
- Authority
- DZ
- Algeria
- Prior art keywords
- pharmaceutical formulations
- formulations
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9417953A GB9417953D0 (en) | 1994-09-03 | 1994-09-03 | Pharmaceutical formulations |
GBGB9503752.9A GB9503752D0 (en) | 1995-02-24 | 1995-02-24 | Pharmaceutical formulations |
US46044195A | 1995-06-02 | 1995-06-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
DZ1926A1 true DZ1926A1 (fr) | 2002-02-17 |
Family
ID=27267365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DZ950107A DZ1926A1 (fr) | 1994-09-03 | 1995-08-02 | Formulations pharmaceutiques. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0782443A1 (fr) |
JP (1) | JPH10505595A (fr) |
AU (1) | AU3471995A (fr) |
DZ (1) | DZ1926A1 (fr) |
IL (1) | IL115125A0 (fr) |
MA (1) | MA23663A1 (fr) |
TR (1) | TR199501082A2 (fr) |
WO (1) | WO1996007408A1 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR004510A1 (es) | 1995-09-07 | 1998-12-16 | Smithkline Beecham Plc | Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento |
DE69815833T2 (de) * | 1997-02-14 | 2004-05-19 | Laboratoire Glaxosmithkline S.A.S. | Amoxicillin und clavulanat enthaltende arzneizubereitungen |
US6706290B1 (en) | 1998-07-06 | 2004-03-16 | Olvai E. Kajander | Methods for eradication of nanobacteria |
WO2000001238A1 (fr) * | 1998-07-06 | 2000-01-13 | Kajander E Olavi | Procedes relatifs a l'elimination des nanobacteries |
US7250176B1 (en) | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
WO2002030392A2 (fr) | 2000-10-12 | 2002-04-18 | Beecham Pharmaceuticals (Pte) Limited | Nouvelle formulation |
US8614315B2 (en) * | 2009-12-25 | 2013-12-24 | Mahmut Bilgic | Cefdinir and cefixime formulations and uses thereof |
TR201000688A2 (tr) | 2010-01-29 | 2011-08-22 | B�Lg�� Mahmut | Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar. |
WO2011152809A2 (fr) * | 2010-06-03 | 2011-12-08 | Bilgic Mahmut | Formulations effervescentes comprenant de la céphalosporine et de l'acide clavulcanique |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0002312B1 (fr) * | 1977-11-26 | 1982-02-03 | Beecham Group Plc | Dérivés de l'acide clavulanique et compositions pharmaceutiques les contenant |
NZ198241A (en) * | 1980-09-27 | 1983-12-16 | Beecham Group Ltd | Tablet containing amoxycillin and potassium clavulanate |
DE69425131T2 (de) * | 1993-01-22 | 2001-03-15 | Smithkline Beecham Plc | Verwendung von clavulansäure und einem antibiotikum zur behandlung von infektionen |
-
1995
- 1995-08-02 DZ DZ950107A patent/DZ1926A1/fr active
- 1995-08-21 AU AU34719/95A patent/AU3471995A/en not_active Abandoned
- 1995-08-21 JP JP8509160A patent/JPH10505595A/ja not_active Ceased
- 1995-08-21 EP EP95931176A patent/EP0782443A1/fr not_active Withdrawn
- 1995-08-21 WO PCT/EP1995/003322 patent/WO1996007408A1/fr not_active Application Discontinuation
- 1995-08-31 TR TR95/01082A patent/TR199501082A2/xx unknown
- 1995-09-01 MA MA24005A patent/MA23663A1/fr unknown
- 1995-09-01 IL IL11512595A patent/IL115125A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO1996007408A1 (fr) | 1996-03-14 |
IL115125A0 (en) | 1995-12-31 |
JPH10505595A (ja) | 1998-06-02 |
AU3471995A (en) | 1996-03-27 |
EP0782443A1 (fr) | 1997-07-09 |
TR199501082A2 (tr) | 1996-06-21 |
MA23663A1 (fr) | 1996-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9610153A (pt) | Formulações farmacêuticas | |
BR9611626A (pt) | Formulações farmacéuticas | |
FR2705566B1 (fr) | Nouvelles compositions pharmaceutiques. | |
TR199901077A3 (tr) | Ispençiyari formülasyonlar. | |
BR9607851B1 (pt) | combinaÇço e formulaÇço farmacÊutica. | |
DE69530325D1 (de) | Aerosol-arzneiformulierungen | |
FI971279A (fi) | Lääkkeitä | |
DE69525148T2 (de) | Pharmazeutische formulierung | |
NO954486D0 (no) | Farmasöytiske formuleringsgrunnlag | |
ID24654A (id) | Formulasi farmasi omeprazola | |
NO981008D0 (no) | Farmasöytisk formulering | |
DZ1559A1 (fr) | Compositions pharmaceutiques. | |
DZ1926A1 (fr) | Formulations pharmaceutiques. | |
ID16781A (id) | Formulasi-formulasi farmasi | |
ITMI941169A0 (it) | Formulazioni farmaceutiche | |
BR9507768A (pt) | Composição farmacêutica | |
MX9200532A (es) | Agente farmaceuticos. | |
FI973230A (fi) | Uusi farmaseuttinen formulaatio | |
MA26604A1 (fr) | Compositions pharmaceutiques. | |
FI951155A0 (fi) | Farmaseuttinen valmiste | |
FI923371A (fi) | En farmaceutisk formulation. | |
TR199601018A1 (tr) | Farmasötik bilesikler. | |
DZ2159A1 (fr) | Produits pharmaceutiques. | |
NL1004386A1 (nl) | Mondverzorgingsmiddel. | |
SE9404467D0 (sv) | Drug formulations |